Overview

Hyperpolarized Xenon-129 MR Imaging of the Lung

Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
Over the past 10 years, electronic cigarettes (e-cigarettes, EC) have been commercialized as a "less harmful" alternative to traditional cigarettes.1,2 However, e-cigarettes are believed to cause pulmonary epithelial, endothelial and vascular dysfunction, and to cause murine phenotypes similar to those of human COPD. Recently, "spiked" vape juice has been linked to severe lung damage. Unfortunately, the effects of e-cigarettes on the human lungs are still poorly understood, especially in healthy young adults. Therefore, establishing the health effects of e-cigarettes in humans is of paramount importance to guide medical and regulatory decision making. Its widespread use and immense popularity among teenagers and young adults have caused major concern given potentially significant addictive and detrimental long-term health effects.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Virginia
Collaborator:
Duke University
Treatments:
Xenon